Comparison between Ursodeoxycholic acid and Silymarin in Anticonvulsive drugs induced Hypertransaminasemia

Ursodeoxycholic acid and methotrexate for primary biliary cirrhosis

Journal of Hepatology ◽

10.1016/s0168-8278(01)80199-9 ◽

2001 ◽

Vol 34 (0) ◽

pp. 59 ◽

Cited By ~ 2

Author(s):

I Copaci

Keyword(s):

Primary Biliary Cirrhosis ◽

Ursodeoxycholic Acid ◽

Biliary Cirrhosis

Download Full-text

Ursodeoxycholic acid normalizes the 15 years survival in German patients with primary biliary cirrhosis and normal serum bilirubin levels at baseline

Zeitschrift für Gastroenterologie ◽

10.1055/s-0029-1241240 ◽

2009 ◽

Vol 47 (09) ◽

Author(s):

ME Pascu ◽

K Neumann ◽

P Martus ◽

B Schlosser ◽

A Felder ◽

...

Keyword(s):

Primary Biliary Cirrhosis ◽

Ursodeoxycholic Acid ◽

Serum Bilirubin ◽

Normal Serum ◽

Biliary Cirrhosis

Download Full-text

Serum IgG4 and long term outcome in patients with primary biliary cholangitis treated with ursodeoxycholic acid

Zeitschrift für Gastroenterologie ◽

10.1055/s-0036-1586984 ◽

2016 ◽

Vol 54 (08) ◽

Author(s):

ME Pascu ◽

M Riedel ◽

E Schott ◽

B Wiedenmann ◽

T Berg ◽

...

Keyword(s):

Ursodeoxycholic Acid ◽

Primary Biliary Cholangitis ◽

Term Outcome ◽

Long Term Outcome ◽

Serum Igg4

Download Full-text

Ursodeoxycholic acid role in chronic cholecystitis progression prevention in acromegaly patients receiving somatostatin analogues

Endocrine Abstracts ◽

10.1530/endoabs.32.p872 ◽

2013 ◽

Author(s):

Yuriy Poteshkin ◽

Vyacheslav Pronin ◽

Evgeny Pronin ◽

Evgenia Kotlyarevskaya ◽

Maria Morozova

Keyword(s):

Ursodeoxycholic Acid ◽

Somatostatin Analogues ◽

Chronic Cholecystitis

Download Full-text

24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis

10.26226/morressier.572768e5d462b8029237f482 ◽

2016 ◽

Author(s):

Martina Sombetzki

Keyword(s):

Liver Fibrosis ◽

Inflammatory Response ◽

Ursodeoxycholic Acid ◽

Murine Model

Download Full-text

Ursodeoxycholic acid in the domestic pharmaceutical market

Gastroenterology Suppl Consilium Medicum ◽

10.26442/2414-3529_2018.1.36-42 ◽

2018 ◽

pp. 36-42

Author(s):

E.Y. Plotnikova ◽

◽

A.S. Suhih ◽

Keyword(s):

Ursodeoxycholic Acid ◽

Pharmaceutical Market

Download Full-text

A case of symptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid.

Kanzo ◽

10.2957/kanzo.33.552 ◽

1992 ◽

Vol 33 (7) ◽

pp. 552-555

Author(s):

Motoyoshi YANO ◽

Hirotomo TAKESHIMA ◽

Naoki HISHIDA ◽

Hisao HAYASHI ◽

Nobuo SAKAMOTO

Keyword(s):

Ursodeoxycholic Acid ◽

Primary Sclerosing Cholangitis ◽

Sclerosing Cholangitis

Download Full-text

Trial of Ursodeoxycholic Acid (UDCA) for Parkinson's Disease: The "UP" Study

Case Medical Research ◽

10.31525/ct1-nct03840005 ◽

2000 ◽

Author(s):

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Ursodeoxycholic Acid

Download Full-text

Faculty Opinions recommendation of Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1088191.541204 ◽

2007 ◽

Author(s):

Cynthia Ko

Keyword(s):

Ursodeoxycholic Acid ◽

Muscle Contractility ◽

Cholesterol Gallstones

Download Full-text

Faculty Opinions recommendation of Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1097921.602437 ◽

2009 ◽

Author(s):

Dominique Eladari ◽

Kent Riemondy

Keyword(s):

Ursodeoxycholic Acid ◽

Human Liver ◽

Liver Cells ◽

Human Liver Cells ◽

Alternate Promoter

Download Full-text